Lumos Diagnostics Sets Q3 Reporting Date and Investor Webinar as SPP Approaches Closing
Lumos Diagnostics Holdings Ltd (LDX.AX, LDXHF) has confirmed the release date for its Q3 FY26 results and an investor webinar, while its Share Purchase Plan (SPP) enters its final days. The company will report results on April 20 and host a webinar on April 21 to discuss performance and recent developments, including progress with its FebriDx test in the US.
Topics: Capital Raising Company Updates Earnings Report Investor Relations Share Purchase Plan